Stay updated on AXS-12 in Narcolepsy: Efficacy & Safety - Clinical Trial
Sign up to get notified when there's something new on the AXS-12 in Narcolepsy: Efficacy & Safety - Clinical Trial page.

Latest updates to the AXS-12 in Narcolepsy: Efficacy & Safety - Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedRevision history updated: added Revision v3.5.0 and removed Revision v3.4.3.SummaryDifference0.0%

- Check15 days agoChange DetectedRevision: v3.4.3 was added; Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check43 days agoChange DetectedAdded Narcolepsy as a condition and a Genetic and Rare Diseases Information Center resource; updated to Revision v3.4.2. Removed the funding-status notice and the prior revision note (v3.4.1).SummaryDifference0.4%

- Check50 days agoChange DetectedA government funding/status notice was added at the top of the page and the revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check57 days agoChange DetectedThe new page adds a 'Show glossary' option and the labels 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. The previous version displayed 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check72 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to AXS-12 in Narcolepsy: Efficacy & Safety - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AXS-12 in Narcolepsy: Efficacy & Safety - Clinical Trial page.